The 2001 Bethesda System

Fuente: Redalyc
Enregistré dans:
Détails bibliographiques
Auteur principal: Christine Bergeron
Format: Artículo científico
Langue:en
Publié: Instituto Nacional de Salud Pública 2003
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1876462797108281344
author Christine Bergeron
author_facet Christine Bergeron
contents The 2001 Bethesda System Christine Bergeron Salud Bethesda System cervical cancer cytology screening human papillomavirus The Bethesda system is a system of terminology for reportingthe results of cervical cytology. It was developed in 1988,and is now widely used in the United States. This system wasupdated in April 2001. The most important modificationsare the following: a) elimination of the category “satisfactorybut limited by”, b) the reintegration of benign modificationsin the normal category, c) “atypical squamous cells of undeterminedsignificance” is now named “atypical squamous cells”and subdivided into “atypical squamous cells ofundetermined significance” and “cannot exclude high gradesquamous intraepithelial lesion”; and d) endocervical adenocarcinomain situ which is now a separate entity. Low gradesquamous intraepithelial lesions and high grade squamous intraepithelialcells remain unchanged. Recommendations havebeen proposed concerning automated review and ancillarytesting. This paper is available too at: http://www.insp.mx/salud/index.html 2003 artículo científico 0036-3634 https://www.redalyc.org/articulo.oa?id=10609707 en http://www.redalyc.org/revista.oa?id=106 Salud Pública de México application/pdf Instituto Nacional de Salud Pública Salud Pública de México (México) Num.3 Vol.45
format Artículo científico
id redalyc_10609707
institution Redalyc
language en
publishDate 2003
publisher Instituto Nacional de Salud Pública
spellingShingle The 2001 Bethesda System
Christine Bergeron
Salud
Bethesda System
cervical cancer
cytology screening
human papillomavirus
The 2001 Bethesda System Christine Bergeron Salud Bethesda System cervical cancer cytology screening human papillomavirus The Bethesda system is a system of terminology for reportingthe results of cervical cytology. It was developed in 1988,and is now widely used in the United States. This system wasupdated in April 2001. The most important modificationsare the following: a) elimination of the category “satisfactorybut limited by”, b) the reintegration of benign modificationsin the normal category, c) “atypical squamous cells of undeterminedsignificance” is now named “atypical squamous cells”and subdivided into “atypical squamous cells ofundetermined significance” and “cannot exclude high gradesquamous intraepithelial lesion”; and d) endocervical adenocarcinomain situ which is now a separate entity. Low gradesquamous intraepithelial lesions and high grade squamous intraepithelialcells remain unchanged. Recommendations havebeen proposed concerning automated review and ancillarytesting. This paper is available too at: http://www.insp.mx/salud/index.html 2003 artículo científico 0036-3634 https://www.redalyc.org/articulo.oa?id=10609707 en http://www.redalyc.org/revista.oa?id=106 Salud Pública de México application/pdf Instituto Nacional de Salud Pública Salud Pública de México (México) Num.3 Vol.45
title The 2001 Bethesda System
topic Salud
Bethesda System
cervical cancer
cytology screening
human papillomavirus
url https://www.redalyc.org/articulo.oa?id=10609707